Life Sciences Insurance

What You Need Now, What You’ll Need Next, and How to Buy It Without Overpaying

Home » Insurance By Industry » Life Sciences Insurance: Guide for Biotech, Med Device & Pharma
Life sciences leadership team discussing growth-stage risk planning, highlighting Life Sciences Insurance strategy from preclinical to commercial stage

Index

Gordon B. Coyle

CEO, The Coyle Group
845-474-2924

How to get started

  • Book a free 30-minute call with our insurance expert.
  • Get your tailored Life Sciences Insurance quote.
  • We handle the transition and ensure zero coverage gaps.
Book a call and get covered!

Executive Summary

Life sciences risk is not “office risk.” One clinical trial adverse event, one product recall, or one data breach can become a seven-figure problem overnight.
If your company develops drugs, medical devices, diagnostics, or digital health products, you need insurance designed for the specific exposures you face. This guide covers the complete insurance stack for life sciences companies, from preclinical startups to commercial-stage enterprises.

  • This guide is for: Biotech companies, medical device manufacturers, pharmaceutical firms, diagnostics companies, digital health/SaMD, CROs, and CDMOs.
  • What you’ll learn: Stage-based insurance requirements, COI checklist for contracts, and how to get quotes faster without overpaying.

The Bottom Line (TL;DR)

Key Takeaway

Details

Life sciences insurance is a stack, not one policy

You need 8-12+ policies working together

D&O insurance triggers early

Required before revenue when raising capital

Clinical trial liability is specialized

Standard GL excludes human subject exposures

COI requirements delay deals

Missing endorsements stall CRO/hospital contracts

Product liability grows at commercial stage

Limits often need to reach $5M-$10M+

Cyber/data risk is underestimated

Patient data + IP creates dual exposure

Investment Range:

  • Pre-seed/Seed: $15,000 – $50,000 annually
  • Series A/B (clinical stage): $50,000 – $150,000 annually
  • Commercial stage: $150,000 – $500,000+ annually
Schedule a Call

To discuss your life sciences insurance needs.

What Does “Life Sciences Insurance” Actually Mean?

Life sciences insurance is not a single policy. It is a coordinated stack of coverages designed to address the unique exposures biotech, pharma, medical device, and digital health companies face throughout their product lifecycle.

The Three Risk Buckets (Plain English):

Risk Category

What It Protects

Key Policies

People Risk

Leadership, employees, board members

D&O, EPLI, Workers’ Comp

Product/Clinical Risk

Patients, trial subjects, end users

Product Liability, Clinical Trial Liability, Professional Liability

Operations/Data Risk

Labs, vendors, IP, patient data

Cyber, Property, Crime, Business Interruption

Standard business insurance cannot adequately cover these exposures. Generic policies contain exclusions that leave life sciences companies exposed precisely when they need protection most.

Why Life Sciences Companies Get Surprised by Insurance Gaps

The core problem is that fast growth, investor requirements, and clinical milestones outpace most founders’ understanding of insurance needs.

What 40+ Years Taught Me About This Risk

In my four decades helping companies navigate insurance challenges, I have seen the same pattern repeatedly: founders assume their existing coverage handles everything until a claim reveals painful gaps. The companies that avoid this trap treat insurance as a strategic function, not an administrative afterthought.

The Five Most Common Insurance “Surprises”

1. GL Excludes Clinical and Product Specifics

Standard general liability insurance contains exclusions for clinical trials and specific product liability scenarios. Many founders discover this only after an incident.

2. D&O Is Not “Later”

Fundraising triggers D&O insurance requirements immediately. Investors and board members will not serve without it. Waiting until Series A to purchase D&O is too late.

3. Clinical Trials Require Specialized Wording

Ethics committees and hospital IRBs require specific policy language. According to FDA requirements, trial sponsors must demonstrate adequate insurance coverage before approval.

4. Vendor Contracts Demand Endorsements

You May Not Have CROs, CDMOs, and hospital partners require specific insurance exhibits. Missing “additional insured” or “waiver of subrogation” language delays deals for weeks.

5. Cyber/Data Obligations Outpace Coverage

Patient data, clinical trial information, and proprietary IP create exposures that basic cyber insurance may not fully address. HIPAA compliance alone is insufficient.

What Insurance Do Life Sciences Companies Need?

Policy

What It Protects

When Essential

General Liability (GL)

Third-party bodily injury, property damage

Day one

Product Liability

Injuries from your drug/device/product

Before human exposure

Clinical Trial Liability

Trial participant injuries, adverse events

Before IND/IDE submission

D&O (Directors & Officers)

Personal liability for leadership decisions

Before taking investment

E&O / Tech E&O

Professional services errors, software failures

When providing services/software

Cyber Insurance

Data breaches, ransomware, privacy violations

Day one

EPLI

Employment discrimination, wrongful termination

When hiring employees

Crime

Wire fraud, social engineering, employee theft

Day one

Property + Business Interruption

Lab equipment, facility damage, lost revenue

When you have physical assets

Workers’ Compensation

Employee injuries

When hiring employees

Umbrella/Excess

Higher limits over GL/auto/employers liability

When contracts require >$1M limits

Cargo/Transit

Shipped samples, materials, products

When shipping regulated materials

Which Coverages Matter Most for Your Business Type?

If You’re a Biotech Company (Preclinical/Clinical)

Top Priorities:

  • D&O Insurance: Required by investors before funding closes. Private company D&O protects founders and board members from personal liability.
  • Clinical Trial Liability: Mandatory for ethics committee approval. Policies should carry minimum limits of $1M, with upper limits reaching $10M-$20M for larger trials.
  • Cyber Insurance: Protects patient data and proprietary research. Understanding what cyber insurance covers prevents gaps.
  • EPLI: Employment claims increase as you scale. EPLI coverage protects against discrimination, harassment, and wrongful termination claims.

If You’re a Medical Device Company

Top Priorities:

  • Product Liability + GL: Structure must address completed operations exposure. Medical device recalls increased 13.8% in Q1 2024, reaching 296 events.
  • Product Recall Insurance: Notification, retrieval, and disposal costs are not covered under standard GL. According to industry data, non-routine quality events cost the medical device industry $2.5 billion to $5 billion annually.
  • Post-Market Surveillance Exposure: Once your device reaches consumers, liability exposure expands significantly.

If You’re Diagnostics/Lab Services

Top Priorities:

  • Professional Liability (E&O): Covers errors in test results, misdiagnosis support.
  • Privacy/Cyber: Lab data contains protected health information requiring robust cyber protection.
  • Lab Operations Property: Specialized equipment, samples, and temperature-controlled storage require proper valuation.

If You’re a CRO or CDMO

Top Priorities:

  • Professional Liability: Your services supporting drug/device development create E&O exposure.
  • Contractual Liability Alignment: Your GL must not exclude the contractual liabilities you assume.
  • Umbrella/Excess: Higher limits are typically required by sponsor companies.

If You’re Digital Health / SaMD (Software as Medical Device)

Top Priorities:

Not sure which bucket you’re in?

Schedule a 15-minute call

To map your specific coverage needs.

What Changes as You Move from Preclinical to Clinical to Commercial?

Preclinical Stage (Before Humans)

“Minimum Viable Stack”:

  • D&O (board/investor readiness)
  • EPLI (when you have employees)
  • Cyber (protecting research data)
  • General Liability
  • Property (lab equipment)

Key Considerations:

  • Investors will require D&O before funding closes
  • Board members will not serve without coverage
  • Even pre-revenue companies face employment claims

Clinical Stage (Humans Involved)

Additional Requirements:

  • Clinical Trial Liability (mandatory for IRB approval)
  • Enhanced Product Liability
  • International trial coverage (if conducting trials abroad)

Key Considerations:

  • Ethics committees require specific policy language
  • Trial locations affect coverage requirements
  • Protocol deviation claims create exposure
  • Trial sponsor vs. investigator responsibilities must be clearly defined

Commercial Stage (Selling Product)

Expanded Requirements:

  • Product Liability becomes primary focus (limits often $5M-$10M+)
  • Distribution contracts require additional insureds
  • Product recall and withdrawal coverage becomes essential
  • Higher umbrella limits (often $10M+)

Key Considerations:

  • Post-market surveillance creates ongoing exposure
  • International distribution expands jurisdictional risk
  • Customer contracts often dictate minimum limits

What Do Investors, Partners, CROs, and Hospitals Typically Require on a COI?

Certificate of Insurance (COI) requirements are where deals get delayed. Understanding what third parties require prevents contract holdups.

Common COI Requirements

Requirement

Typical Specification

Why They Ask

Limits

$1M/$2M GL, $5M-$10M Product Liability

Ensures you can cover potential claims

Additional Insured

Their entity named on your policy

Extends your coverage to protect them

Primary & Noncontributory

Your policy pays first

Prevents disputes over payment priority

Waiver of Subrogation

You waive right to sue them via your insurer

Protects them from your insurer’s claims

Notice of Cancellation

30 days written notice

Prevents coverage lapses they don’t know about

COI Readiness Checklist

  • GL with adequate completed operations limits
  • Product Liability with clinical trial coverage (if applicable)
  • Ability to add additional insureds without charge
  • Primary & noncontributory endorsement available
  • Waiver of subrogation endorsement available
  • 30-day notice of cancellation language
  • Umbrella/Excess providing follow-form coverage
Organized insurance documents reviewed by a life sciences executive, illustrating Life Sciences Insurance COI readiness for CRO, hospital, and partner contract requirements

Why Deals Get Delayed:

CROs, CDMOs, and hospital partners have insurance requirements baked into their standard contracts. If your coverage cannot provide the required endorsements, contract execution stalls for weeks while you scramble to upgrade coverage.

Real Claim Examples: Which Policy Responds?

Scenario

Responding Policy

Trial participant alleges injury from investigational drug

Clinical Trial Liability

FDA-approved device causes injury after commercial launch

Product Liability / GL Completed Ops

Patient data breached in ransomware attack

Cyber Insurance

Investor alleges misleading disclosures during fundraise

D&O

CRO claims you breached contract terms

Depends (E&O/GL, often excluded if poorly structured)

Employee files wrongful termination lawsuit

EPLI

Wire transfer fraud during vendor payment

Crime Insurance

Lab freezer failure destroys research samples

Property + Spoilage (if endorsed)

Real-World Example: Clinical Trial Adverse Event

A mid-stage biotech company conducting a Phase II trial experienced a serious adverse event requiring hospitalization of a trial participant. The investigation took 8 months.

Without Proper Coverage:

  • Legal defense costs: $400,000+
  • Settlement: $1.2M
  • FDA response coordination: $150,000
  • Business interruption during investigation: Unquantifiable damage to investor confidence

With Clinical Trial Liability:

  • Insurer provided defense counsel
  • Settlement paid within policy limits
  • Crisis management support included
  • Company continued operations without material impact

How Much Coverage Should You Buy (Limits) at Each Stage?

Framework for Setting Limits

  • What contracts require (floor): Start with contractual minimums
  • Worst realistic scenario (ceiling): Consider multi-plaintiff potential
  • How many parties could claim at once (multiplier): Clinical trials = hundreds of potential claimants

Typical Starting Points by Stage

Stage

GL

Product Liability

D&O

Cyber

Preclinical

$1M/$2M

$2M-$5M

$2M-$5M

$1M-$2M

Clinical

$1M/$2M

$5M-$10M

$5M-$10M

$2M-$5M

Commercial

$2M+

$10M-$25M+

$10M+

$5M+

When Umbrella/Excess Makes Sense:

Umbrella policies provide additional limits over underlying GL, auto, and employers liability. When contract requirements exceed your primary policy limits, umbrella coverage is more cost-effective than increasing primary limits.

Retentions/Deductibles:

Higher retentions reduce premium but require capital reserves. A $25,000 retention on cyber versus a $5,000 retention could save 15-20% on premium but requires planning for that out-of-pocket exposure.

What Drives the Cost of Life Sciences Insurance?

Factor

Impact on Premium

What You Can Control

Stage (preclinical vs. commercial)

Higher human exposure = higher cost

N/A

Trial size and geography

More participants, more countries = higher cost

Trial design

Product type (implantable vs. non-invasive)

Implantables cost significantly more

N/A

Revenue and distribution footprint

Higher revenue = higher exposure base

N/A

Claims history

Previous claims increase rates

Risk management

Data sensitivity and controls

Poor controls = higher cyber cost

Security posture

Contractual risk transfer language

Assuming more risk = higher cost

Contract negotiation

How to Lower Costs

  • Document safety and compliance programs: Underwriters reward demonstrated risk management.
  • Implement strong cyber security controls: MFA, EDR, and backup testing reduce cyber premiums.
  • Negotiate vendor contracts carefully: Do not assume liability you cannot insure.
  • Work with a specialized broker: Life sciences insurance requires market knowledge that generalist brokers lack.

What Exclusions and “Gotchas” Should You Watch For?

Common Policy Pitfalls

Exclusion/Limitation

What It Means

Why It Matters

Professional services carve-out

E&O exposure not covered under GL

Creates gap if you provide consulting/services

Clinical trial exclusion on GL

Standard GL excludes human subject exposure

Must have separate clinical trial policy

Recall not included

Product retrieval costs excluded

Recall costs can reach $500K+ quickly

Cyber waiting periods

Coverage only after 8-12 hour waiting period

Short outages not covered

Contractual liability limitation

Assumed liabilities excluded

Contracts often require you to assume liability

“Insured vs. insured” (D&O)

Claims between company parties excluded

Founder disputes may not be covered

Prior acts / retro dates

Pre-policy conduct excluded

Changing carriers creates exposure

Simple Rule: If it is in your contract, make sure it is in your policy wording.

What Do Underwriters Ask For (Quote-Ready Checklist)?

Having these materials ready accelerates the quoting process from weeks to days.

Documentation Required

  • One-page company overview (what you do, stage, funding)
  • Product description + intended use + mechanism of action
  • Clinical trial information (if applicable): countries, participant count, protocol summary
  • Manufacturing and QA documentation (ISO certifications, GMP compliance, supplier list)
  • Top 2-3 contracts with insurance exhibits
  • Data handling overview (HIPAA compliance, PHI/PII handling, vendor security)
  • Loss history (any claims in past 5 years)
  • Financials and funding stage
  • Organizational chart / board composition (for D&O)
Life sciences executive preparing underwriting documents and compliance materials, showing Life Sciences Insurance quote readiness and risk review preparation

How to Buy Life Sciences Insurance Without Wasting Money

The Three-Step Plan

Step 1: Map Your Model + Stage

Identify what exposures you truly have based on your current operations and near-term milestones. Do not buy coverage for risks you do not face yet.

Step 2: Match Policies to Contracts + Milestones

Ensure your coverage meets COI requirements for partners, investors, and customers. Build in coverage for milestones you expect to hit within the policy term.

Step 3: Stress-Test Limits + Wording

Review policy language against realistic claim scenarios. Confirm your coverage actually responds when you need it.

Common Buying Mistakes to Avoid

  • Buying generic GL only: Does not address clinical, product, or professional liability
  • Waiting until after term sheets/contracts: Insurance requirements delay closings
  • Underinsuring D&O during fundraising: Investors and board members require adequate protection
  • Ignoring cyber/crime because “we’re not IT”: Patient data and wire transfer fraud affect all life sciences companies

When Should You Talk to a Specialist Broker?

Trigger Events

  • Raising capital or adding board members
  • Starting a clinical trial (IND/IDE submission)
  • Signing with CRO, CDMO, or hospital partner
  • Shipping or handling regulated materials
  • Launching or commercializing a product
  • Expanding internationally

What a Specialist Broker Actually Does

  • Translates your science into language underwriters understand
  • Accesses markets that generalist brokers cannot
  • Negotiates policy terms based on life sciences precedent
  • Updates your program as you hit milestones
  • Advocates during claims (when it matters most)

Your Next Step

Stop guessing whether your coverage actually protects you.

Schedule a 20-Minute Coverage Map Call

Walk us through your company stage, upcoming milestones, and current coverage. We will identify gaps and provide a clear Good/Better/Best recommendation tailored to your situation.

Request a Quote

If you already know what you need, send us your information and we will return quotes from carriers who actually understand life sciences risk.

Schedule a Call Request a Quote

We respond within one business day. Your science is too important to leave unprotected.

Questions about Life Sciences Insurance?

Biotech startups need a minimum insurance stack that includes Directors and Officers (D&O) liability insurance if taking investment, general liability insurance, cyber insurance, and commercial property insurance. When hiring employees, add Employment Practices Liability Insurance (EPLI) and workers’ compensation. Clinical trial liability insurance becomes mandatory before beginning human studies. The exact requirements depend on your funding stage, whether you have a board of directors, and your near-term clinical milestones.

Yes, biotech companies need D&O insurance before generating revenue. D&O insurance protects directors and officers personally for decisions made in their leadership capacity, regardless of company revenue. Venture capital investors require D&O insurance before funding closes. Board members and independent directors typically refuse to serve without D&O coverage in place. The personal liability exposure exists from the moment leadership decisions are made, not from when revenue begins.

No, standard general liability insurance policies contain exclusions for clinical trials and human subject research. You need a separate clinical trial liability insurance policy with specific language that ethics committees and Institutional Review Boards (IRBs) will accept. This is one of the most common and costly coverage gaps in life sciences insurance programs. Clinical trial liability policies typically carry minimum limits of $1 million and can have upper limits of $10 million to $20 million or more.

Clinical trial liability insurance covers injuries to trial participants from investigational products that have not yet received regulatory approval. Product liability insurance covers injuries from products that have received FDA approval and are being sold commercially. During the clinical development phase, a life sciences company may need both coverages. Clinical trial liability responds during the investigation phase, while product liability becomes the primary coverage once the product reaches market.

Hospitals and Contract Research Organizations (CROs) typically require $1 million per occurrence and $2 million aggregate general liability limits, plus $5 million to $10 million in product liability or clinical trial liability coverage. Larger academic medical centers and major CROs may require $10 million or more in umbrella coverage. Requirements also include additional insured status, primary and noncontributory endorsements, and waiver of subrogation. These requirements are specified in the insurance exhibit section of partnership contracts.

Digital health companies need both Tech E&O insurance and cyber insurance because they address different exposures. Tech Errors and Omissions (E&O) insurance covers professional liability for software failures, algorithm errors, data-driven misdiagnosis, and technology services that fail to perform as promised. Cyber insurance covers data breaches, ransomware attacks, privacy violations, and incident response costs. A digital health platform handling patient data faces both technology performance liability and data security liability, making both coverages essential.

Life sciences insurance costs vary significantly by company stage. Pre-seed and seed stage companies typically pay $15,000 to $50,000 annually for a basic insurance stack. Series A and Series B companies in clinical stages typically pay $50,000 to $150,000 annually due to clinical trial liability requirements. Commercial stage companies with products on the market typically pay $150,000 to $500,000 or more annually because product liability limits must increase substantially. Costs are driven by trial size, product type, revenue, claims history, and required policy limits.

A Certificate of Insurance (COI) is a document proving your insurance coverage meets the requirements specified in a contract. COIs delay life sciences deals when companies cannot provide required endorsements such as additional insured status, primary and noncontributory language, or waiver of subrogation. CROs, CDMOs, and hospital partners have insurance requirements built into standard contracts. If your policy cannot accommodate these endorsements, contract execution stalls for weeks while you upgrade coverage or negotiate alternative terms.

Life sciences companies should watch for clinical trial exclusions in general liability policies, product recall exclusions in product liability policies, professional services carve-outs that create E&O gaps, contractual liability limitations that exclude assumed liabilities, prior acts or retroactive date restrictions in claims-made policies, and cyber insurance waiting periods that exclude short outages. The “insured versus insured” exclusion in D&O policies can also exclude claims between founders or company parties. Always verify that exposures in your contracts are covered in your policy wording.

Simple life sciences insurance programs with standard coverages can bind within one to two weeks if all documentation is ready and submitted. Complex programs involving clinical trials, international operations, novel products, or unique risk profiles may take four to six weeks for underwriting review and policy issuance. Starting the insurance process 90 days or more before your coverage need date is recommended. Having a complete submission package ready, including company overview, product descriptions, clinical trial protocols, and financial information, significantly accelerates the quoting and binding process.

Why Life Sciences Companies Choose The Coyle Group

Most brokers treat life sciences insurance like standard business coverage. They quote generic policies, miss critical exclusions, and leave you scrambling when a CRO contract demands endorsements your policy cannot provide.

We take a different approach.

  • We speak your language. When you mention IND submissions, IRB requirements, or Phase II enrollment targets, we understand what that means for your insurance program. You will not waste time educating your broker on basics.
  • We know what breaks deals. After 40+ years working with growth companies, we have seen every COI requirement that delays contracts. We structure your program to meet partner requirements before they become emergencies.
  • We plan for where you are going, not just where you are. Your Series A coverage should anticipate Series B requirements. Your preclinical program should have a clear path to clinical trial coverage. We build insurance programs that scale with your milestones.
  • We fight for you at claims time. Insurance is only valuable if it pays when you need it. We advocate aggressively during claims, ensuring your coverage responds as intended.

95+

Years of Family Legacy in Insurance

40+

Years Personal Experience

95%

Client Retention Rate

600+

Educational Videos

Schedule your strategy call

This article was written by Gordon B. Coyle, CPCU, ARM, AMIM, PWCA, CEO of The Coyle Group, who has over 40 years of experience working with business owners of all sizes and industries across the United States, solving their insurance challenges. Gordon specializes in helping life sciences companies, including biotech startups, medical device manufacturers, and pharmaceutical firms, develop comprehensive insurance programs that protect their operations and support their growth from preclinical through commercial stages.

Here’s how to take the next step

Schedule Your Insurance Confidence Assessment

In our 30-minute call, you’ll discover:

  • Whether your current coverage matches your actual risks
  • If you’re getting fair value for what you’re paying
  • How your service experience compares to what’s possible
  • What questions you should be asking but probably aren’t
Schedule My Assessment Call

Not ready for a call?

Get Free Access to Our Gated Video:
“How to Finally Feel Confident in Your Coverage. “

And discover the exact system we use to help business owners eliminate hidden coverage gaps, stop overpaying, and finally feel confident in their protection.

What Peace of Mind Looks Like

Trusted by business owners across the U.S.

Read client reviews of The Coyle Group
  • The Coyle Group is 1st class! Gordon and his team are knowledgeable, responsive, and attentive to detail. Gordon is that rare breed of professional who genuinely cares for his clients and works hard to exceed their expectations. I highly recommend them.
    Jeff Carton
    Partner, Denlea & Carton, LLP
  • The insurance brokerage service was truly tailored to my needs, nothing like those big brokers who steer you toward random policies that don’t fit your profile. Thank you to the team for your help.
    Yohann Josselin
    Founder & Director, RankForge
  • I was working with another broker and having difficulty acquiring General Liability coverage. A colleague recommended The Coyle Group. They were able to get coverage bound in just a couple of business days and a policy issued in ten days, and with a solid carrier at a competitive premium. Truly impressive results, plus it was a pleasure working with them. I highly recommend the Coyle Group!
    Tim McCarthy
    Director of Operations, Dalmatian Company LLC
  • If any business is looking to work with an insurance brokerage firm that is not only excellent at what the firm does, but one that deeply values the needs of the clients, then The Coyle Group is the firm for you. Give them a call and see for yourself. I can assure that you will quickly agree.
    Dahiema Grant
    Accountant, DSG Advisory CPA

Want to know more?

See related blogs